ProMIS Neurosciences, Inc. (PMN)
8.755
-0.34
(-3.79%)
USD |
NASDAQ |
Dec 11, 16:00
8.50
-0.26
(-2.91%)
After-Hours: 07:32
ProMIS Neurosciences Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.0051M |
| Aurinia Pharmaceuticals, Inc. | -14.04M |
| Edesa Biotech, Inc. | 0.00 |
| Lexaria Bioscience Corp. | -0.1579M |
| Xenon Pharmaceuticals, Inc. | 38.76M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.18M |
| Cash from Financing (Quarterly) | 21.26M |
| Free Cash Flow | -27.36M |
| Free Cash Flow Per Share (Quarterly) | -0.2085 |
| Free Cash Flow to Equity (Quarterly) | -10.18M |
| Free Cash Flow to Firm (Quarterly) | -10.18M |
| Free Cash Flow Yield | -8.26% |